TrialCNS drugs2015

Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial.

Cheryl H Waters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.